Torben Ek

Implementing data on targeted therapy from the INFORM registry platform for children with relapsed cancer in

Sofia Wallin, Ingrid Ora, Gabriela Prochazka, Johanna Sandgren, Caroline Bjorklund, Gustaf Ljungman, Hartmut Vogt, Torben Ek, Cornelis M. van Tilburg, Anna Nilsson
FRONTIERS IN ONCOLOGY - 2024

Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With

Cancer.

Elisabeth Wadensten, Sandra Wessman, Frida Abel, Teresita Diaz De Ståhl, Bianca Tesi, Christina Orsmark Pietras, Linda Arvidsson, Fulya Taylan, Susanne Fransson, Hartmut Vogt, Anna Poluha, Sailendra Pradhananga, Maria Hellberg, Kristina Lagerstedt-Robinson, Praveen Raj Somarajan, Sofie Samuelsson, Sara Orrsjö, Khurram Maqbool, Karin Henning, Tobias Strid, Torben Ek, Henrik Fagman, Thomas Olsson Bontell, Tommy Martinsson, Florian Puls, Per Kogner, Valtteri Wirta, Cornelis Jan Pronk, Joakim Wille, Richard Rosenquist, Monica Nistér, Fredrik Mertens, Magnus Sabel, Ulrika Norén-Nyström, Pernilla Grillner, Ann Nordgren, Gustaf Ljungman, Johanna Sandgren, David Gisselsson
JCO precision oncology - 2023

Effect of Radiotherapy Dose on Outcome in Nonmetastatic

Sarcoma

J. Kersting, A. Ranft, V. Bhadri, B. Brichard, S. Collaud, S. Cyprova, H. Eich, Torben Ek, H. Gelderblom, J. Hardes, L. Haveman, W. Hartmann, P. Hauser, P. Heesen, H. Jurgens, J. Kanerva, T. Kuhne, A. Raciborska, J. Rascon, V. Rechl, A. Streitburger, B. Timmermann, Y. Uhlenbruch, U. Dirksen
Advances in Radiation Oncology - 2023

Nurses' Perceptions of the Impact of a National Educational Program in Pediatric Oncology Nursing: A Cross-Sectional

Evaluation

M. A. Sandeberg, Maria Olsson, Torben Ek, K. Enskar, Margaretha Stenmarker, P. Pergert
Journal of Pediatric Hematology-Oncology Nursing - 2023

Combined vitamin D, ibuprofen and glutamic acid decarboxylase-alum treatment in recent onset Type I diabetes: lessons from the DIABGAD randomized pilot

trial.

Johnny Ludvigsson, Indusmita Routray, Sriramulu Elluru, Per Leanderson, Helena E Larsson, Björn Rathsman, Ragnar Hanås, Annelie Carlsson, Torben Ek, Ulf Samuelsson, Torun Torbjörnsdotter, Jan Åman, Eva Örtqvist, Karun Badwal, Craig Beam, Rosaura Casas
Future science OA - 2020

Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC)

consortium.

Alba Rubio-San-Simón, Nicolas André, Maria Giuseppina Cefalo, Isabelle Aerts, Alicia Castañeda, Sarah Benezech, Guy Makin, Natasha van Eijkelenburg, Karsten Nysom, Lynley Marshall, Marion Gambart, Raquel Hladun, Claudia Rossig, Luca Bergamaschi, Franca Fagioli, Ben Carpenter, Stephane Ducassou, Cormac Owens, Ingrid Øra, Antonio Juan Ribelles, Bram De Wilde, Pilar Guerra-García, Marion Strullu, Carmelo Rizzari, Torben Ek, Simone Hettmer, Nicolas U Gerber, Christine Rawlings, Manuel Diezi, Sauli Palmu, Antonio Ruggiero, Jaime Verdú, Teresa de Rojas, Gilles Vassal, Birgit Geoerger, Lucas Moreno, Francisco Bautista
European journal of cancer (Oxford, England : 1990) - 2020

Validation of a flow cytometry-based detection of γ-H2AX, to measure DNA damage for clinical

applications.

Pegah Johansson, Anders Fasth, Torben Ek, Ola Hammarsten
Cytometry. Part B, Clinical cytometry - 2017

IL-6 as a possible marker of high risk

neutropenia

Isabella Donnér, Torben Ek, Jonas Abrahamsson
NOPHO Annual Meeting Abstracts, 19-23 May 2017 Stockholm, PO-16 - 2017

A flow cytometry assay that measures cellular sensitivity to DNA-damaging agents, customized for clinical routine

laboratories.

Sherin T Mathew, Pegah Johansson, Yue Gao, Anders Fasth, Torben Ek, Ola Hammarsten
Clinical biochemistry - 2016

Loss of the DNA Damage Repair Kinase ATM Impairs Inflammasome-Dependent Anti-Bacterial Innate

Immunity.

Saskia F Erttmann, Anetta Härtlova, Marta Sloniecka, Faizal A M Raffi, Ava Hosseinzadeh, Tomas Edgren, Reza Rofougaran, Ulrike Resch, Maria Fällman, Torben Ek, Nelson O Gekara
Immunity - 2016

Hypomorphic mutations of SEC23B gene account for mild phenotypes of congenital dyserythropoietic anemia type

II.

Roberta Russo, Concetta Langella, Maria Rosaria Esposito, Antonella Gambale, Francesco Vitiello, Fara Vallefuoco, Torben Ek, Elizabeth Yang, Achille Iolascon
Blood cells, molecules & diseases - 2013

Lupus anticoagulants in two children-bleeding due to nonphospholipid-dependent antiprothrombin

antibodies.

Karin Knobe, Ulf Tedgård, Torben Ek, Per-Erik Sandström, Andreas Hillarp
European journal of pediatrics - 2012

Multivariate analysis of the relation between immune dysfunction and treatment intensity in children with acute lymphoblastic

leukemia.

Torben Ek, Mats Josefson, Jonas Abrahamsson
Pediatric blood & cancer - 2011

Incidence and survival analyses in children with solid tumours diagnosed in Sweden between 1983 and

2007.

Gustaf Ljungman, Ake Jakobson, Mikael Behrendtz, Torben Ek, Lars-Göran Friberg, Ulf Hjalmars, Lars Hjorth, Jack Lindh, Niklas Palmqvist, Bengt Sandstedt, Gustaf Österlundh
Acta paediatrica (Oslo, Norway : 1992) - 2011

[PVL positive Staph aureus as the cause of necrotizing pneumonia. Description of three severe cases in earlier healthy young

persons]

Torben Ek, O. Andersson, A. U. Kasemo, M. Wede, P Nilsson
Lakartidningen - 2007

Normal Immune Response at one Month after Treatment for Pediatric Solid

Tumours

Torben Ek, Lotta Mellander, Mirjana Hahn-Zoric, Jonas Abrahamsson
Pediatric Blood & Cancer - 2006

Avidity of tetanus and Hib antibodies after childhood acute lymphoblastic leukaemia - implications for vaccination

strategies.

Torben Ek, Lotta Mellander, Mirjana Hahn-Zoric, Jonas Abrahamsson
Acta paediatrica (Oslo, Norway : 1992) - 2006

Ara-C Fever and Febrile Episodes after High Dose Ara-C in Pediatric Lymphoid

Malignancies

Torben Ek, Mirka Pinkava, Jonas Abrahamsson, Marianne Jarfelt
Pediatric Blood & Cancer - 2005

Immune reconstitution after childhood leukemia. Aspects on immunizations and effects of Ara-C on the innate immune

system

Torben Ek
2005

Ara-C fever and infections after high-dose ara-C treatment in pediatric lymphoid

malignancies

Torben Ek, M. Pinkava, Jonas Abrahamsson
J Pediatr Hematol Oncol - 2005

Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk

group

Torben Ek, Lotta Mellander, B. Andersson, Jonas Abrahamsson
Pediatr Blood Cancer - 2005

Re-immunisations after childhood

leukaemia

Torben Ek, Lotta Mellander, Jonas Abrahamsson
Eur J Haematol - 2005

Interferon gamma and tumour necrosis factor alpha in relation to anaemia and prognosis in childhood

cancer

Torben Ek, Lotta Mellander, Jonas Abrahamsson
Acta Paediatr - 2005

Immune Reconstitution after Treatment for Childhood Acute Lymphoblastic Leukemia is most Disturbed in the High-risk

Group

Torben Ek, Lotta Mellander, Bengt A. Andersson, Jonas Abrahamsson
Pediatric Blood & Cancer - 2004

The paediatric cytarabine syndrome can be viewed as a drug-induced cytokine release

syndrome

Torben Ek, Jonas Abrahamsson
Br J Haematol - 2004

Intensive treatment for childhood acute lymphoblastic leukemia reduces immune responses to diphtheria, tetanus, and Haemophilus influenzae type

b

Torben Ek, Lotta Mellander, M. Hahn-Zoric, Jonas Abrahamsson
J Pediatr Hematol Oncol - 2004

Proinflammatory cytokines mediate the systemic inflammatory response associated with high-dose cytarabine treatment in

children.

Torben Ek, Marianne Jarfelt, Lotta Mellander, Jonas Abrahamsson
Medical and pediatric oncology - 2001

Torben Ek

Anknuten till forskning

Publikationer